Article

Promising Experimental MS Drugs Highlight Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/promising-experimental-ms-drugs-highlight-specialt" target="_blank">View the story "Promising Experimental MS Drugs Highlight Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Related Content
Gene editing in chronic hepatitis B -- Image credit: 红 王 | stock.adobe.com
April 22nd 2025

PBGENE-HBV Granted FDA Fast Track Designation for Chronic Hepatitis B

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Composition with pills of Bayer Aspirin
April 17th 2025

High-Dose Aspirin With IVIG Does Not Meaningfully Reduce Coronary Artery Lesions in Children With Kawasaki Disease

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Microscopic View of Blood Cells Related to Aplastic Anemia
April 16th 2025

Allogeneic T Regulatory Cell Product CK0801 Granted FDA Orphan Drug Designation for Aplastic Anemia Treatment

Luke Halpern, Assistant Editor
Health care professional holding a hepatitis liver. -- Image credit: mi_viri | stock.adobe.com
April 15th 2025

Study: Hepatic PTPRD Expression Impaired in Etiologies of Chronic Liver Disease Associated With Metabolic Disease

Gillian McGovern, Associate Editor